Question · asked by 1 review
DDAVP vs placebo or usual care: All‐cause mortality
- Population
- participants with platelet dysfunction undergoing surgery
- Intervention
- DDAVP
- Comparison
- placebo or usual care
- Outcome
- All‐cause mortality
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
DDAVP vs placebo or standard care: platelet dysfunction subgroup All‐cause mortality · participants with platelet dysfunction undergoing surgery Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane Headline outcomes only | 0.72 [0.12, 4.22] | 7 studies · 422 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Desmopressin use for minimising perioperative blood transfusion 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- DDAVP vs placebo or usual care · participants undergoing surgery · 1 review
- DDAVP vs aprotinin · participants undergoing surgery · 1 review
- DDAVP vs tranexamic acid (control) · participants undergoing surgery · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.